Development of implantable hydroxypropyl-β-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors
Crossref DOI link: https://doi.org/10.1007/s10847-014-0422-6
Published Online: 2014-06-06
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Varan, Cem
Bilensoy, Erem
Text and Data Mining valid from 2014-06-06